Genome-wide Gene/Exon expression analysis of late stage NSCLC treated by Erlotinib /Bevacizumab: role of tumor-stroma interactions
01.02.2013
Genome-wide Gene/Exon expression analysis of late stage NSCLC treated by Erlotinib /Bevacizumab: role of tumor-stroma interactions
Grundlagenforschung -
01.02.2013 - 01.06.2015
Abgeschlossen
Projektleitung: Baty Florent
Mitarbeiter/innen: Brutsche Martin, Oliver Dürr, Franzini Anca
Weiter